Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids)
Abd Elaleem, A., Ahmed, D., Saif, M. (2022). Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids). EKB Journal Management System, 3(2), 196-212. doi: 10.21608/ejmr.2022.240113
Abd Elrahman Shaban Ahmed Abd Elaleem; Doaa Mohamed Ahmed Ahmed; Mohamed Yasser Sayed Saif. "Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids)". EKB Journal Management System, 3, 2, 2022, 196-212. doi: 10.21608/ejmr.2022.240113
Abd Elaleem, A., Ahmed, D., Saif, M. (2022). 'Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids)', EKB Journal Management System, 3(2), pp. 196-212. doi: 10.21608/ejmr.2022.240113
Abd Elaleem, A., Ahmed, D., Saif, M. Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids). EKB Journal Management System, 2022; 3(2): 196-212. doi: 10.21608/ejmr.2022.240113

Dry Eye Changes After Phacoemulsification After Using Oral Linoleinic Acid (Omega 3 Fatty Acids)

Egyptian Journal of Medical Research
Article 14, Volume 3, Issue 2, April 2022, Page 196-212  XML PDF (630.53 K)
Document Type: Original Article
DOI: 10.21608/ejmr.2022.240113
View on SCiNiTO View on SCiNiTO
Authors
Abd Elrahman Shaban Ahmed Abd Elaleem; Doaa Mohamed Ahmed Ahmed; Mohamed Yasser Sayed Saiforcid
Ophthalmology department, Faculty of Medicine, Beni-Seuf University, Egypt
Abstract
The current study was designed to evaluate the effect of oral linoleinec acid (omega 3 fatty acid) on patients who complained from dryness after Phacoemulsification. It was a Cross-Sectional study conducted first of April 2020 to end of February 2021 in the ophthalmology department at Beni-Suef University Hospital, and included 107 participants that had Phacoemulsification surgery, (60.7% males and 39.3% females), their age ranged from (48) to (71) with an average age of (62.07 ±6.03) years old. All participants were subjected to full clinical and laboratory investigations and received oral linoleinic acid capsules 1000 mg for 3 months after operation. Dry-eye markers including the ocular surface disease index (OSDI) and subjective symptom questionnaire, tear-film assessment using Schirmer testing 2, and break–up time test was sequentially evaluated preoperatively and postoperatively at 1st day,1st week, 1st month, 2nd month and 3rd month. Written Informed consent had been taken from all studied participants prior to beginning of the study. OSDI scores decreased significantly between baseline and three months post-operatively, YBUT scores increased significantly between baseline and three months post-operatively and Schirmer test scores increased significantly between baseline and three months post-operatively. Based on our results, oral omega-3 supplements could be safely added to the postoperative protocols following phacoemulsification to reduce the incidence of postoperative dry eye syndrome.
Keywords
Cataract; Phacoemulsification; (omega 3 fatty acid)
References
  1. Fry, L. L., Garg, A., Guitérrez-Camona, F., Pandey, S. K., & Tabin, G. (Eds.). (2004). Clinical practice in small incision cataract surgery. CRC Press.‏
  2. Pflugfelder, S. C., & Stern, M. E. (2020). Biological functions of tear film. Experimental eye research, 108115.‏
  3. Kanski, J. J., & Bowling, B. (2011). Clinical ophthalmology: a systematic approach. Elsevier Health Sciences.‏
  4. Xi, L., Gu, Y. S., & Xu, Y. S. (2008). Changes of tear film and tear secretion after phacoemulsification in diabetic patients. Journal of Zhejiang University Science B, 9(4), 324-328.‏
  5. Schmidl, D., Werkmeister, R., Kaya, S., Unterhuber, A., Witkowska, K. J., Baumgartner, R., ... & Garhöfer, G. (2017). A controlled, randomized double-blind study to evaluate the safety and efficacy of chitosan-N-acetylcysteine for the treatment of dry eye syndrome. Journal of Ocular Pharmacology and Therapeutics, 33(5), 375-382.‏
  6. Kalupahana, N. S., Goonapienuwala, B. L., & Moustaid-Moussa, N. (2020). Omega-3 fatty acids and adipose tissue: inflammation and browning. Annual Review of Nutrition, 40, 25-49.‏
  7. Lollett, I. V., & Galor, A. (2018). Dry eye syndrome: developments and lifitegrast in perspective. Clinical Ophthalmology (Auckland, NZ), 12, 125.‏
  8. Perez, V. L., Stern, M. E., & Pflugfelder, S. C. (2020). Inflammatory basis for dry eye disease flares. Experimental Eye Research, 201, 108294.‏
  9. Pellegrini, M., Senni, C., Bernabei, F., Cicero, A. F., Vagge, A., Maestri, A., ... & Giannaccare, G. (2020). The role of nutrition and nutritional supplements in ocular surface diseases. Nutrients, 12(4), 952.‏
  10. Gupta, P. K., Drinkwater, O. J., VanDusen, K. W., Brissette, A. R., & Starr, C. E. (2018). Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. Journal of Cataract & Refractive Surgery, 44(9), 1090-1096.‏
  11. Starr, C. E., Gupta, P. K., Farid, M., Beckman, K. A., Chan, C. C., Yeu, E., ... & ASCRS Cornea Clinical Committee. (2019). An algorithm for the preoperative diagnosis and treatment of ocular surface disorders. Journal of Cataract & Refractive Surgery, 45(5), 669-684.‏
  12. Karpecki, P. M., Prokopich, C. L., Racine, L., Bitton, E., Caffery, B., Harasymowycz, P., ... & Ashkenas, J. (2017). Dry Eye Diseases and Ocular Surgery: Practical Guidelines for Canadian Eye Care Practitioners. Canadian Journal of Optometry, 79(4), 19-33.‏
  13. Caffery, B., Srinivasan, S., Reaume, C. J., Fischer, A., Cappadocia, D., Siffel, C., & Chan, C. C. (2019). Prevalence of dry eye disease in Ontario, Canada: a population-based survey. The ocular surface, 17(3), 526-531.‏
  14. Arita, R., Mizoguchi, T., Kawashima, M., Fukuoka, S., Koh, S., Shirakawa, R., ... & Morishige, N. (2019). Meibomian gland dysfunction and dry eye are similar but different based on a population-based study: the Hirado-Takushima study in Japan. American journal of ophthalmology, 207, 410-418.‏
  15. El Sayed, Y. M., Elhusseiny, A. M., Gawdat, G. I., & Elhilali, H. M. (2021). One-year results of two-site trabeculotomy in paediatric glaucoma following cataract surgery. Eye, 35(6), 1637-1643.‏
  16. Karpecki, P. M., Prokopich, C. L., Racine, L., Bitton, E., Caffery, B., Harasymowycz, P., ... & Ashkenas, J. (2017). Dry Eye Diseases and Ocular Surgery: Practical Guidelines for Canadian Eye Care Practitioners. Canadian Journal of Optometry, 79(4), 19-33.‏
  17. Mohammadpour, M., Mehrabi, S., Hassanpoor, N., & Mirshahi, R. (2017). Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: a randomized clinical trial. Journal of current ophthalmology, 29(1), 33-38.‏
  18. Qiu, J. J., Sun, T., Fu, S. H., Yu, Y. F., You, Z. P., Zhang, Q., ... & Wang, Z. H. (2020). A study of dry eye after cataract surgery in MGD patients. International ophthalmology, 40(5), 1277-1284.‏
  19. Cagini, C., Torroni, G., Mariniello, M., Di Lascio, G., Martone, G., & Balestrazzi, A. (2021). Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders. International Ophthalmology, 1-7.‏
  20. Saini, R. K., & Keum, Y. S. (2018). Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance—A review. Life sciences, 203, 255-267.‏
  21. Saif, M. Y. S., & ATS, S. (2015). Saif charity campaigns. Cataract Cornea, 21, 39-43.‏
  22. Sun, M., Moreno, I. Y., Dang, M., & Coulson-Thomas, V. J. (2020). Meibomian Gland Dysfunction: What Have Animal Models Taught Us?. International Journal of Molecular Sciences, 21(22), 8822.‏
  23. Beltrán-Zambrano, E., García-Lozada, D., & Ibáñez-Pinilla, E. (2019). Risk of cataract in smokers: A meta-analysis of observational studies. Archivos de la Sociedad Española de Oftalmología (English Edition), 94(2), 60-74.‏
  24. Han, X., Wu, C., Yan, X., Keel, S., Shang, X., Zhang, L., & He, M. (2020). Are smoking intensity and cessation related to cataract surgical risk in diabetic patients? Findings from the 45 and Up Study. Eye, 34(2), 383-391.‏
  25. Srinivasan, S., Raman, R., Swaminathan, G., Ganesan, S., Kulothungan, V., & Sharma, T. (2017). Incidence, progression, and risk factors for cataract in type 2 diabetes. Investigative ophthalmology & visual science, 58(13), 5921-5929.‏
  26. Das, T., Behera, U. C., Bhattacharjee, H., Gilbert, C., Murthy, G. V. S., Rajalakshmi, R., ... & SPEED Study group. (2020). Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report# 1. Eye disorders in people with type 2 diabetes mellitus. Indian journal of ophthalmology, 68(Suppl 1), S16.‏
  27. Israfilova, G. Z. (2019). “Important Players” in the Development of Age-Related Cataracts (Literature Review). Ophthalmology in Russia, 16(1S), 21-26.‏
  28. Ling, C. N. Y., Lim, S. C., Jonas, J. B., & Sabanayagam, C. (2021). Obesity and risk of age-related eye diseases: a systematic review of prospective population-based studies. International Journal of Obesity, 1-23.‏
  29. Wang, J. J., Rochtchina, E., Tan, A. G., Cumming, R. G., Leeder, S. R., & Mitchell, P. (2009). Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology, 116(4), 652-657.‏
  30. Xu, Y., He, J., Lin, S., Zhang, B., Zhu, J., Resnikoff, S., ... & Zou, H. (2018). General analysis of factors influencing cataract surgery practice in Shanghai residents. BMC ophthalmology, 18(1), 1-8.‏
  31. Hugosson, M., & Ekström, C. (2020). Prevalence and risk factors for age-related cataract in Sweden. Upsala Journal of Medical Sciences, 125(4), 311-315.‏
  32. Tang, Y., Wang, X., Wang, J., Jin, L., Huang, W., Luo, Y., & Lu, Y. (2018). Risk factors of age‐related cataract in a Chinese adult population: the Taizhou Eye Study. Clinical & experimental ophthalmology, 46(4), 371-379.‏
  33. Ordiñaga-Monreal, E., Castanera-Gratacós, D., Castanera, F., Fambuena-Muedra, I., Vega, F., & Millán, M. S. (2021). Pupil size differences between female and male patients after cataract surgery. Journal of Optometry.‏
  34. Ipek, T. (2020). DRY EYE AND CATARACT SURGERY (Doctoral dissertation, UNIVERSIDAD COMPLUTENSE DE MADRID).‏
  35. Deinema, L. A., Vingrys, A. J., Wong, C. Y., Jackson, D. C., Chinnery, H. R., & Downie, L. E. (2017). A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease. Ophthalmology, 124(1), 43-52.‏
  36. Park, J., Yoo, Y. S., Shin, E., Han, G., Shin, K., Lim, D. H., & Chung, T. Y. (2020). Effects of the re-esterified triglyceride (rTG) form of omega-3 supplements on dry eye following cataract surgery. British Journal of Ophthalmology.‏
  37. Zhu, W., Wu, Y., Li, G., Wang, J., & Li, X. (2014). Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials. Nutrition reviews, 72(10), 662-671.‏
  38. Molina‐Leyva, I., Molina‐Leyva, A., & Bueno‐Cavanillas, A. (2017). Efficacy of nutritional supplementation with omega‐3 and omega‐6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials. Acta ophthalmologica, 95(8), e677-e685.‏
  39. Kangari, H., Eftekhari, M. H., Sardari, S., Hashemi, H., Salamzadeh, J., Ghassemi-Broumand, M., & Khabazkhoob, M. (2013). Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology, 120(11), 2191-2196.
  40. Kesba, M. M., Saif, M. Y., & Saeed, M. A. (2021). Effect of omega-3 fatty acids on dry eye following phacoemulsification. Delta Journal of Ophthalmology, 22(2), 97.‏
  41. Ong, N. H., Purcell, T. L., Roch-Levecq, A. C., Wang, D., Isidro, M. A., Bottos, K. M., ... & Schanzlin, D. J. (2013). Epithelial healing and visual outcomes of patients using omega-3 oral nutritional supplements before and after photorefractive keratectomy: a pilot study. Cornea, 32(6), 761-765.‏
  42. Asbell PA, Maguire MG, Pistilli M, Ying GS, Szczotka-Flynn LB, Hardten DR, Lin MC, Shtein RM. Dry Eye Assessment and Management Study Research Group. (2018). n− 3 Fatty acid supplementation for the treatment of dry eye disease. New England Journal of Medicine, 378(18), 1681-1690.‏
Statistics
Article View: 398
PDF Download: 1,141